Company Filing History:
1 out of 1,567 
1 out of 4,446 
Years Active: 1994-2002
Title: Joann Strnad: Innovator in Neurotensin Research
Introduction
Joann Strnad is a notable inventor based in Yardley, PA (US). She has made significant contributions to the field of neurotensin research, holding a total of 2 patents. Her work focuses on the development of novel methods and compounds that have potential applications in medical diagnostics and treatment.
Latest Patents
Strnad's latest patents include groundbreaking inventions related to nucleic acids encoding the human neurotensin subtype 2 receptor. These patents describe the long form and shorter isoform of the neurotensin receptor subtype 2, known as HNT2R (long) and HNT2R (short). The inventions also provide polypeptides with specific amino acid sequences and methods for isolating and cloning receptors expressed from the novel HNT2R cDNAs. This research aims to facilitate the development of high-throughput screens to identify novel neurotensin agonists and antagonists. Additionally, her patent on vectors and DNAs for the expression of a human adenocarcinoma antigen includes novel recombinant DNA compounds that encode a 40,000 dalton adenocarcinoma antigen recognized by monoclonal antibody KS 1/4. These expression vectors can be utilized to produce KSA derivatives and subfragments, which are valuable for diagnosing and treating various adenocarcinomas.
Career Highlights
Throughout her career, Joann Strnad has worked with prominent companies such as American Home Products Corporation and Eli Lilly and Company. Her experience in these organizations has contributed to her expertise in the field of biotechnology and pharmaceuticals.
Collaborations
Some of her notable coworkers include John R Hadcock and Thomas F Bumol. Their collaborative efforts have likely enhanced the impact of her research and inventions.
Conclusion
Joann Strnad's innovative work in neurotensin research and her contributions to the field through her patents highlight her role as a significant inventor. Her advancements have the potential to influence medical diagnostics and treatment strategies in the future.